Tasso

Overview

Builds home diagnostic blood collection devices that help patients and clinicians support virtual care, frequent monitoring, and more informed healthcare decisions without traditional needle draws.

Part of the Seattle ecosystem

Related

• Adaptive Biotechnologies ($ADPT)Develops immune-system-based diagnostics and data tools, including NGS MRD testing, for clinicians and biopharma in clinical practice, drug trials, and medicine development.
• Allen Institute for Brain ScienceBuilds brain cell atlases, connectome maps, and analysis platforms to help researchers study mammalian brain organization across development, evolution, disease, and regions.
• ARCH Venture PartnersBuilds and backs science-based companies, investing flexibly in portfolio businesses founded around technologies intended to affect human health and disease.
• BMS Cell Therapy Washington ($BMY)Develops, manufactures, and commercializes cancer immunology and cell therapies for people with difficult-to-treat cancers and other serious diseases with unmet medical needs.
• Fred Hutchinson Cancer CenterProvides cancer patient care, scientific research, education and training, plus giving and fundraising support for patients, caregivers, clinicians, researchers, and donors.
• Institute for Systems BiologyConducts systems biology research on cancer, health, infectious disease, chronic illness, and environment, while providing education, publications, open-source software, and proteomics services.
• Lumen BioscienceDevelops biologic drugs using spirulina algae to make and deliver therapeutic proteins, addressing scalability and cost barriers in biologic drug development.
• Nautilus Biotechnology ($NAUT)Develops a proteomics platform using Iterative Mapping to quantify proteins and proteoforms, helping researchers study proteome complexity and generate biological insights.
• Sana Biotechnology ($SANA)Builds engineered cell medicines that repair or control genes, or replace damaged cells, for patients with diseases including diabetes, B-cell cancers, and autoimmune disorders.
• Umoja BiopharmaDevelops in vivo CAR T cell therapies and lentiviral manufacturing to support on-demand treatment, aiming to reduce ex vivo manufacturing delays for patients.
• Variant BioDevelops precision medicines using genomic data from people with exceptional health traits to identify genetically supported targets for inflammation, fibrosis, muscle disorders, and high-unmet-need diseases.
• XanfabBuilds mission-critical circuit card assemblies, PCB assemblies, precision lead-formed components, and electro-mechanical products for aviation, space, and defense manufacturing needs.